Twist Bioscience Corporation Common Stock

TWSTNASDAQUSD
60.94 USD
2.09 (3.55%)AT CLOSE (11:59 AM EDT)
62.12
1.18 (1.94%)
POST MARKET (AS OF 07:49 PM EDT)
Post Market
AS OF 07:49 PM EDT
62.12
1.18 (1.94%)
🔴Market: CLOSED
Open?$59.62
High?$61.77
Low?$58.52
Prev. Close?$58.85
Volume?945.4K
Avg. Volume?1.2M
VWAP?$60.42
Rel. Volume?0.76x
Bid / Ask
Bid?$52.78 × 100
Ask?$72.45 × 100
Spread?$19.67
Midpoint?$62.62
Valuation & Ratios
Market Cap?3.7B
Shares Out?61.3M
Float?52.8M
Float %?86.1%
P/E Ratio?N/A
P/B Ratio?8.19
EPS?-$1.25
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?3.78Strong
Quick Ratio?3.37Strong
Cash Ratio?1.85Strong
Debt/Equity?0.03Low
ValuationRICHLY VALUED
Score
50/100
P/E?
N/A
P/B?
8.19HIGH
P/S?
9.54HIGH
P/FCF?
N/A
EV/EBITDA?
-31.0CHEAP
EV/Sales?
9.20HIGH
Returns & Efficiency
ROE?
-16.8%WEAK
ROA?
-12.0%WEAK
Cash Flow & Enterprise
FCF?$-86724000
Enterprise Value?$3.6B
Fundamentals ratios updated end of day
xxx
Related Companies
Loading...
News
Profile
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.
Employees
979
Market Cap
3.7B
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
2018-10-31
Address
681 GATEWAY BLVD.
SOUTH SAN FRANCISCO, CA 94080
Phone: 800-719-0671